Building Your Export Cost Base

Export pricing starts with a rigorous understanding of your total export cost base — not just production cost. The full export cost for a Turkish medical device includes: manufacturing cost (direct materials + labour + overhead), quality and regulatory costs (ISO 13485 audit allocation, CE marking maintenance, EUDAMED registration), packaging and labelling (market-specific labelling adds cost per market), logistics and freight (sea vs air, insurance, Incoterm-specific cost allocation), import duties (vary by market and HS code — some markets have 0% for CE-certified medical devices; others up to 15%), local registration costs (often borne by the distributor but sometimes subsidised by the manufacturer), after-sales service costs (training, warranty, repair logistics), and marketing and trade fair support costs. Manufacturers who price from manufacturing cost alone systematically undercharge and erode margins as markets mature and cost support demands increase.

Market-Specific Pricing: The Tiered Approach

Medical device pricing should be tiered by market economic level, competitive landscape, regulatory barriers, and customer willingness to pay. A practical three-tier framework: Tier 1 — Premium markets (Germany, Netherlands, Switzerland, USA, Australia): price at 80–90% of the leading competitor's list price; compete on value, not discount; highlight CE MDR compliance and clinical evidence. Tier 2 — Mid-tier markets (Spain, Italy, Poland, Saudi Arabia, UAE, Turkey): price at 60–75% of Western European list price; balance quality positioning with competitive accessibility; distributor margin typically 30–40%. Tier 3 — Developing markets (Egypt, Nigeria, Indonesia, Bolivia): price at 30–50% of Tier 1; CE marking is the quality credential; price competitiveness and distributor financing capability are primary buying criteria. This tiered model must be managed carefully — distributors in higher-tier markets must never be able to access product at the lower-tier price, otherwise the pricing architecture collapses.

Distributor Margin Structures

Distributor margins in medical devices vary significantly by product category, market, and service requirements. Typical ranges: disposables and consumables: 25–40% distributor margin; basic capital equipment: 30–45%; complex capital equipment requiring clinical support: 40–55%; in-vitro diagnostics: 35–50% (including reagent margin). When setting ex-factory prices for distributors, structure the price to allow the distributor to achieve a satisfactory end-customer price at their required margin level. Common errors: setting ex-factory prices too high, leaving the distributor insufficient margin to compete; or setting prices too low, leaving manufacturer margin insufficient to support regulatory and marketing investments. The ideal structure is one where both manufacturer and distributor are earning sustainable margins simultaneously — which requires understanding the competitive price level in each market.

Avoiding Parallel Imports

Parallel imports — where product purchased in a low-price market is re-exported and sold in a high-price market — are a significant risk for tiered pricing strategies. A Turkish manufacturer selling at EUR 40 ex-factory to an Egyptian distributor who then re-exports to a German distributor at EUR 55 undermines the EUR 180 German market price. Parallel import prevention measures include: contractual territory restrictions in distributor agreements (enforceable in most jurisdictions), market-specific labelling (a product labelled only in Arabic cannot easily be sold in Germany), market-specific HS codes and customs documentation, serial number tracking and UDI-PI (Unique Device Identification — Part Identifier) tracing, and monitoring distributors' actual downstream pricing. Complete prevention of parallel imports is difficult; systematic risk management reduces their impact.

Payment Terms and Currency Risk

Export payment terms must balance the manufacturer's cash flow needs against distributor commercial requirements. Standard terms for well-established relationships: 30–60 day net payment from invoice date. For new relationships or higher-risk markets: Letter of Credit (L/C), advance payment, or documentary collection. Currency management is critical: Turkish manufacturers with EUR or USD costs (imported components, financing) and TRY revenues face currency risk if export pricing is in TRY. Invoicing all exports in USD or EUR is standard practice — this transfers currency risk to the distributor but protects the manufacturer's EUR/USD cost base. For markets with restricted or volatile currencies (Egypt, Nigeria, Argentina), USD invoicing with L/C payment terms is essential.

When to Discount — and When Not To

Systematic discounting erodes price architecture and distributor commitment. The discipline of consistent pricing — honoured across markets, distributor relationships, and time — is a significant competitive asset. When discounting is appropriate: new market entry where price discovery is genuinely occurring; tender pricing where specific competitive intelligence justifies a tactical price; strategic account pricing for exceptionally large volume commitments with guaranteed minimum purchases; and promotional pricing for product launches with time-limited scope. When not to discount: in response to every distributor request without a specific market-based justification; to compete with lower-quality products that are not genuine substitutes; as a substitute for demonstrating clinical value; or to recover lost business with an underperforming distributor who should be replaced rather than subsidised.

Conclusion

Pricing strategy is not a spreadsheet exercise — it is a strategic discipline that determines market positioning, distributor commitment, manufacturer margin sustainability, and long-term brand architecture across multiple markets simultaneously. Turkish medical device manufacturers who invest in rigorous, market-specific pricing strategy will build more profitable, more sustainable international businesses than those who price reactively or treat all markets identically.